3645 results for «566»

Filter By

3645 results

Learn the procedure technique - Lifetime management of aortic stenosis therapy with self-expandable valve

18 Feb 2024 – From PCR Tokyo Valves 2024

In this session, learn all about the excellent characteristics of the latest self-expandable valve system and its use during the lifetime management of aortic stenosis therapy. Find out more about how we can effectively and safely perform procedures for various cases with the latest self-expandable valve,...

TAVI in bicuspid anatomy

18 Feb 2024 – From PCR Tokyo Valves 2024

Delve into the complexities of TAVI within bicuspid anatomy through this selection of cases: learn about the challenges and techniques involved in overcoming the horizontal aorta, explore how to size  the transcatheter aortic valve in severely calcified bicuspid anatomy, and more!

Tricuspid and other structural interventions

18 Feb 2024 – From PCR Tokyo Valves 2024

In this series of submitted cases, explore challenges and bailouts around tricuspid valve intervention and other forms of structural interventions. Learn about a percutaneous solution to acute traumatic pulmonary regurgitation, a rare complication of inadequate sealing caused by anchor slip through the fabric part in a...

Rapid-fire - Pulmonary and tricuspid valve implantation

18 Feb 2024 – From PCR Tokyo Valves 2024

In this series of rapid-fire case submissions, gain insight into pulmonary and tricuspid valve implantation. This session explores cases such as a pulmonary valve-in-valve procedure, dealing with tissue valve degeneration, and valve implantation in a calcified RV-PA conduit.

Rapid-fire - Pulmonary and tricuspid valve implantation

OPTIMUM: Outcomes of Percutaneous RevascularizaTIon for Management of SUrgically Ineligible Patients with Multivessel or Left Main Coronary Artery Disease

04 Nov 2021

Mirvat Alasnag reviews the OPTIMUM trial, presented by David E. Kandzari, which reports outcomes in a subset of patients who are increasingly seen in modern day catheterization laboratories. It is noteworthy that 1 in 5 patients with left main or multivessel disease are considered surgically ineligible.

Dr. Mirvat Alasnag

Author

Mirvat Alasnag
OPTIMUM: Early Outcomes From a Prospective Registry of PCI in Patients at Prohibitive Risk for CABG
Didn’t find what you were looking for?